Clinical Trials · NCT07361874
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 75
- Start date
- Mar 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in Insulin Sensitivity (M-value), mg/kg/min